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Abstract  
The protein alpha-synuclein (ɑS) self-assembles into small oligomeric species and subsequently into 
amyloid fibrils, that accumulate and proliferate during the development of Parkinson’s disease.  
However, the quantitative characterisation of the aggregation and spreading of ɑS remains 
challenging to achieve. Previously, we identified a conformational conversion step leading from the 
initially formed oligomers to more compact oligomers preceding fibril formation. Here, by a 
combination of single-molecule fluorescence measurements and kinetic analysis, we find that the 
reaction in solution involves two unimolecular structural conversion steps, from the disordered to 
more compact oligomers, and then to fibrils, which can elongate by further monomer addition. We 
have obtained individual rate constants for these key microscopic steps by applying a global kinetic 
analysis to both the decrease in the concentration of monomeric protein molecules and the increase 
in oligomer concentrations over 0.5-140 µM range of ɑS. The resulting explicit kinetic model of ɑS 
aggregation has been used to quantitatively explore seeding the reaction by either the compact 
oligomers or fibrils. Our predictions reveal that, although fibrils are more effective at seeding than 
oligomers, very high numbers of seeds of either type, of the order of 104, are required to achieve 
efficient seeding and bypass the slow generation of aggregates through primary nucleation. 
Complementary cellular experiments demonstrated that two orders of magnitude lower numbers of 
oligomers were sufficient to generate high levels of reactive oxygen species, suggesting that 
effective templated seeding is likely to require both the presence of template aggregates and 
conditions of cellular stress.  
 
Significance Statement 
Growing experimental evidence suggests that the pathological spreading of alpha-synuclein 
aggregates in Parkinson’s disease is mediated through a process of templated seeding whereby 
aggregates catalyse the conversion of soluble protein molecules into their aggregated forms. A 
molecular level understanding of this process is still lacking. Here, we determine the concentrations 
and numbers of aggregates necessary for the effective seeding of alpha-synuclein, thus providing a 
quantitative framework to understand the conditions when its seeded propagation is favourable. We 
find that high concentrations of aggregates are needed for seeding yet that aggregates cause 
cytotoxicity at significantly lower concentrations. This suggests that templated seeding is unlikely to 
be the main mechanism of spreading in Parkinson’s disease but occurs together with oligomer-
induced cellular stress. 
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Introduction  
Neurodegenerative disorders such as Parkinson’s (PD) and Alzheimer’s disease are becoming 
increasingly common as a result of increasing longevity in the population of the modern world, and 
there are no effective disease-modifying therapies to date (1, 2). The main characteristics of these 
disorders are the deposition and spreading of aggregated proteins causing neuronal loss that is 
accompanied with motor and cognitive deficits (3-5).  
Alpha-synuclein (ɑS) is a small (14.5 kDa) intrinsically disordered protein expressed in neurons and 
presynaptic nerve terminals (6). It is abundant in the neuronal cytosol of a healthy brain, and its 
function is thought to be associated with axonal transport (7, 8). The assembly of monomeric ɑS into 
amyloid fibrils that form Lewy Bodies (LBs) and Lewy neurites is a hallmark of PD (9). 
 
The deposition of ɑS inclusions in PD follows a common pattern which correlates with clinical 
symptoms (10). Furthermore, transplanted embryonic neurons in PD patients developed LB deposits, 
suggesting that these aggregates can spread (11). Experiments in wildtype and transgenic mice 
showed that injection of fibrils of recombinant ɑS could lead to the aggregation of the endogenous 
protein, supporting this concept (12-14), and the selective fate of the aggregate-containing neurons 
was demonstrated (15). While the pathological spreading of ɑS has now been reproduced in many 
laboratories, the molecular mechanism of the observed phenomenon is not fully understood and 
this is important for rational development of therapies. One emerging explanation is that is occurs 
by prion-like propagation of ɑS aggregates (16, 17). However, the prion-like role of ɑS in the process 
of its pathological spreading is still under debate (18), and alternative hypotheses exist to explain the 
observations (16). At the molecular level, prion-like propagation is linked to the process of 
templated seeding, in which the aggregates of ɑS enter a cell and act as templates to promote the 
misfolding and aggregation of cellular proteins, resulting in an increased number of aggregates that 
can then spread to neighbouring cells (19). To date, there is a lack of quantitative investigations of 
how many aggregates, either oligomers or fibrils, are needed to promote efficiently the aggregation 
of soluble ɑS, in order to determine and evaluate the conditions when the templated seeding of ɑS 
might be favourable.  
 
To access the quantitative information on the templated seeding requirements for ɑS, it is important 
to achieve a comprehensive understanding of its aggregation pathway. A concentration-dependence 
study can reveal reaction orders of the key steps in a detailed molecular-level mechanism of ɑS 
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aggregation, that can be ultimately used to make predictions of ɑS seeding behaviour. To date, 
evidence has been obtained about the mechanism of ɑS aggregation in solution (20-22) and in the 
presence of lipid membranes that are thought to play an important role in vivo (23-25). Single-
molecule studies combined with detailed kinetic analysis have provided with an opportunity of 
defining the sequence of events during the aggregation process in great detail (26-28). Our related 
studies using single-molecule fluorescence techniques to follow the aggregation of ɑS identified a 
slow conversion step from the initially formed, proteinase K-sensitive oligomers to more compact, 
proteinase K-resistant oligomers. We determined the apparent rates for this process, and showed 
that the converted oligomers caused the highest damage to neuronal cells (27) and were stable with 
respect to the changes in buffer conditions (28). 
 
In the present study, we have extended this approach to analyse the kinetics of aggregation over a 
280-fold range of ɑS concentrations, from 0.5 to 140 µM, and used these data to develop an 
expanded kinetic model for the aggregation of ɑS and to determine the rate constants for the 
individual steps of the reaction. The availability of this model, as well as of data aquired over a wide 
concentration range, allows us to make quantitative predictions of the aggregation behaviour under 
a variety of pre-defined conditions, and calculate the numbers of oligomers and fibrils required for 
the templated seeding of ɑS. This in vitro analysis allows us to assess specifically the propensity of ɑS 
protein to undergo templated seeding process, and reveals that this process will bypass the slow 
nucleation step only under conditions where a high number of aggregates is present within volumes 
of the order of the size of a living cell. Additional quantitative cellular assays reveal that cytotoxicity 
occurs at lower concentrations than that those required for seeding, suggesting that the spreading 
of ɑS under more complex in vivo conditions is likely to involve templated seeding in combination 
with complementary cell-mediated processes. 
 
Results 
Single-molecule FRET measurements show that ɑS oligomers are formed at 0.5-140 µM 
concentrations within several hours 
All the single-molecule experiments were performed with full-length (140-residues) ɑS with an 
alanine to cysteine mutation at residue 90 for fluorophore incorporation (A90C). The attachment of 
Alexa Fluor dyes to the cysteine 90 was demonstrated to have no significant effect on the kinetics of 
fibril formation in our previous studies (27, 28), a result attributable to the fact that this residue is at 
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the periphery of the non-amyloid component (NAC) region, which is a key constituent of ɑS beta-
sheet fibril core. In addition, attachment at this position results in the fluorophores becoming in 
close proximity on the formation of β-sheet structure during aggregation, enabling the conversion 
process to be followed by intermolecular Förster Resonance Energy Transfer (FRET) between dyes 
located on different monomers. Therefore, as has been shown in our previous work (27, 28), lower 
FRET efficiencies are observed for initially formed oligomers lacking significant persistent structure, 
while higher FRET efficiencies are identified for more compact β-sheet-rich oligomers.  
We measured ɑS oligomer formation in solution at physiologically-related pH and 37°C, with initial 
monomer concentrations of 0.5, 5, 10, 35, 70 and 140 µM using single-molecule FRET (sm-FRET) 
technique to follow the changes in the numbers of oligomers in the samples within first 54 hours 
(Fig. 2). In these experiments, using ɑS labelled with Alexa Fluor 488 (ɑS-AF488) and Alexa Fluor 594 
(ɑS-AF594), equimolar quantities of ɑS-AF488 and ɑS-AF594 were mixed to give the chosen starting 
concentration, allowed to aggregate (Fig. 1A), and aliquots were withdrawn for the measurements at 
the times indicated. Upon withdrawal, the solutions were immediately diluted for single-molecule 
analysis, and continuously passed through a microfluidic channel to reduce the sampling time (28, 
29) (Fig. 1B). A 488 nm (blue) laser beam was focussed in the centre of the channel, to excite the 
AF488 dye directly, and the resulting fluorescence was simultaneously collected in both AF488 
(donor) and AF594 (acceptor) channels. AF594 labelled monomers passing through the confocal 
volume are undetectable, whereas AF488 labelled monomers give rise to single bursts in the donor 
channel, enabling the level of monomeric ɑS to be monitored during aggregation reaction. As 
oligomers typically contain both types of label, they are detected as simultaneous intense bursts in 
the donor and the acceptor channels, due to the emission from both the directly excited AF488 and 
from the non-radiatively excited AF594 via FRET. In this manner, oligomers can be distinguished 
from monomers despite the fact that the latter are found at much higher concentrations; and the 
oligomer number and fraction in the solution can be quantified as a function of the reaction time to 
give kinetic profiles of oligomer formation. The analysis of the experimental data is detailed in the 
Methods section and the results are shown in Figure 2. In addition, the intensities recorded in both 
donor and acceptor channels for each oligomer were used to determine its FRET efficiency value (eq. 
1 in Methods), and the FRET efficiency values of all oligomers detected in each sample are shown as 
a FRET efficiency histogram (Fig. 2B), which contains information on both the number of oligomers in 
the sample, and their structural characteristics.  
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Variations in the number of oligomers and their FRET histograms as a function of the starting 
protein concentration 
Within 54 hours of the initiation of the aggregation reaction, oligomer formation was observed for 
all concentrations of ɑS, and the highest concentrations of oligomers were formed in the samples 
with the highest initial protein concentrations, and varied as a function of the initial monomer 
concentration (Fig. 2A). We have performed control experiments in order to verify that we monitor 
the formation of oligomeric aggregates of ɑS, using TEM imaging and sm-FRET measurements with 
removal of fibrils at late incubation times, as detailed in SI Appendix, Figures S1-S3. The FRET 
efficiency histograms of the oligomers probed at various timepoints (Fig. 2B) indicated the existence 
of two distinct populations, the initially formed, disordered “low-FRET” and the more compact, 
“high-FRET” oligomers, in agreement with our previous studies that were carried out at the 70 µM 
concentration of ɑS (27, 28). In these studies, the high-FRET oligomers were found to be more 
proteinase K-resistant, more cytotoxic and more stable towards the changes in buffer conditions 
compared to the low-FRET species, confirming that the changes in the FRET efficiency represent 
changes in ɑS oligomer structure. The experimental data, as previously, were divided into groups 
with different oligomer apparent sizes, based on the number of peaks that were resolvable in the 
FRET efficiency histograms, as shown in SI Appendix, Figure S4. The groups included “small” 
oligomers containing 2-5 monomer units (-mers) which showed one peak in the FRET histograms, 
and “large” oligomers containing 6-150-mers where two peaks could be identified in the FRET 
histograms. Species composed of more than 150-mers, and species occupying neighbouring time 
bins, typically observed in the samples past the first day of incubation, were assumed to arise from 
fibrils and excluded from the measurements (see SI Appendix, Fig. S3). The apparent size estimation 
was based on oligomer brightness, as discussed in detail in SI Appendix, and the overall distributions 
are shown in SI Appendix, Figure S8. This shows that the majority of the species detected at all times 
in the aggregation reaction were smaller than 10-mers. We also performed additional Total Internal 
Reflection Fluorescence Microscopy (TIRFM) measurements to confirm these results, as detailed in 
SI Appendix, Figure S9. In the case of the measurements made on samples with the initial 
concentrations of 35-140 µM, one FRET peak was observed in the histograms of the small oligomers 
at all aggregation times, which could be fitted to a single Gaussian distribution (SI Appendix, eq. S1) 
centred at a FRET efficiency value (E) of 0.5 (SI Appendix, section 1.1). For large oligomers, two 
populations could be distinguished, particularly at late aggregation times, and the histograms were 
globally fitted to double Gaussian functions (SI Appendix, eq. S1), with the E values of 0.4 and 0.6 
(Fig. 2B and SI Appendix, section 1.1). These two populations were assessed to have distinctly 
different kinetic profiles, with the low-FRET population appearing and increasing within the first 24 
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hours of the experiment, but the high-FRET population reaching a maximum value at longer times. 
They were assigned to the two types of ɑS oligomers reported previously (27), the low-FRET and the 
high-FRET oligomers, and the time dependence of these two populations was monitored separately. 
The kinetic traces for these low- and high-FRET species separately are shown in Figure 3B. 
Examination of the histograms obtained for the lowest concentration samples (0.5 µM) showed that 
only the low-FRET population could be observed for the studied aggregation period (SI Appendix, 
Fig. S7B). For the 5 and 10 µM samples, the low-FRET distribution was clearly detectable during the 
first 9 hours of the measurements, whereas at later times the histograms showed a much broader 
single distribution, and the overall oligomer concentrations were extracted without separation into 
the low- and high-FRET sub-populations (Fig. 2B).  
 
ROS measurements 
We have previously reported that oligomers can be taken up rapidly by neurons and astrocytes and 
that the high-FRET oligomers promote the production of reactive oxygen species (ROS) when applied 
to primary neuronal cultures (27). In order to check whether the oligomers of ɑS generated in these 
experiments were able to cause cellular damage, we performed ROS assays and found that the 
oligomers prepared at either 70 or 5 µM initial protein concentration induced the production of ROS, 
as detailed in SI Appendix, section 1.8. and Figure S15. Subsequently, we performed a series of ROS 
measurements to determine the lowest concentration of aggregates needed to be added in order to 
produce detectable ROS (SI Appendix), and this concentration was around 50 pM, which 
corresponds to 30 oligomers per volume approximately corresponding to a single cell (10 µm)3. 
 
The critical aggregation concentration of ɑS is sub-micromolar 
We measured the critical aggregation concentration (CɑS) of ɑS under the conditions used in this 
study, by estimating the total concentration of both monomers and oligomers that were released 
from ɑS fibrils after prolonged incubation of the fibrils in pure buffer solution. TEM images of the 
samples of fibrils after the incubation in buffer are in SI Appendix, Figure S10, and confirm oligomer 
release form the fibrils, in agreement with the observations in our previous work (27). The CɑS value 
corresponds to the total concentration of monomer present in equilibrium with fibrirllar aggregates 
and was measured in supernatants after removal of fibrillar pellets by ultracentrifugation. This 
approach yielded a value of 0.7±0.2 µM. The method used for the CɑS measurement is fully described 
in SI Appendix, section 1.7. This CɑS value is lower than the result in an earlier report, 28 µM, which 
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was measured using quantitative amino acid analysis (20). It is closer to a more recently reported 
value of ca. 2.7 µM, which was obtained from absorption measurements of denatured supernatants 
and subsequent extrapolation to the situation exploring the absence of denaturant (30).  
Kinetic analysis 
Two simple models are consistent with the kinetic data 
In our previous study of the aggregation of ɑS (27), we identified a conversion from relatively 
disordered low-FRET oligomers to more compact high-FRET oligomers, and were able to perform the 
kinetic analysis of these data to provide the rate of this conversion. In light of the previously 
unidentified experimental information on the different protein species formed during the 
aggregation of the protein at different concentrations, we have been able to expand the model 
obtained in the previous study. This yielded an explicit and, importantly, predictive aggregation 
model. Similarly to the earlier analysis, we replace the simplified nucleated polymerization models 
(31-33), in which monomeric units are in direct equilibrium with fibrillar structures, by nucleation-
conversion-polymerization models (34), which introduce a series of conformational conversion steps 
prior to fibril formation. Such a class of models can be solved analytically for early reaction times, 
allowing a global fit to both monomeric and oligomeric data. The simplest such model considers a 
general mechanism whereby low-FRET oligomers are formed from monomeric units in solution. 
These low-FRET oligomers then convert to high-FRET oligomers, which in turn convert into fibrils 
(Fig. 3A). Fibrils then grow by monomer addition as has been inferred from the observation that the 
elongation of the fibrils is initially linear in monomer concentration (22). The assumption of the on-
pathway nature of the oligomers is supported by multiple observations. The presence of the lag 
phase in the formation of high-FRET oligomers relative to that of the low-FRET oligomers suggests 
that these species originate from the rearrangement of their preceding low-FRET species, as an off-
pathway relationship cannot generate such an effect. This is further confirmed by the oligomer 
release upon fibril disaggregation (SI Appendix, Fig. S10), which was previously demonstrated to 
occur with the high-FRET oligomers being released at early times, followed by the low-FRET species 
upon longer incubations (27). By the principle of microscopic reversibility this shows that both high- 
and low-FRET species are on the pathway to form fibrils. In addition, we have recently demonstrated 
a correlation between the rates of the oligomer and fibril formation for ɑS and its pathological 
mutants, particularly the inhibition of both of these processes for A30P variant, further supporting 
the oligomer on-pathway nature (35). Additionally, from the TEM imaging experiments of 
aggregation and disaggregation (SI Appendix, Fig. S2 and S10), the diameters of oligomers and fibrils 
generated in these experiments appear comparable. Lastly, we can directly observe that oligomers 
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can elongate in the presence of freshly added ɑS monomer using TIRFM imaging (SI Appendix, Fig. 
S11). Since sm-FRET data suggest that oligomers account for a very small percentage of total system 
mass throughout the aggregation reaction, this allowed a coarse grained treatment of each oligomer 
population (as described in Methods). The dependence of these conversion processes on oligomer 
size has only a very minor effect on the overall conversion kinetics and thus does not enter the 
analysis and we only consider an average overall flux between populations. These considerations do 
not, however, discriminate between different possible reaction orders of the conversion reactions, 
and so both a monomer independent unimolecular conversion model (Fig. 3A) and a monomer 
dependent bimolecular conversion model (SI Appendix, Fig. S12A) were considered. Lastly, both 
models were simplified by setting the conversion rate constant for the low-FRET to high-FRET 
oligomer conversion step equal to that for the high-FRET oligomer to fibril conversion, since allowing 
these rate constants to differ introduces an extra free parameter to the fitting procedure in each 
case, yet makes no significant difference to the quality of the fits. The kinetic equations and method 
used are discussed in further detail in the Methods section.  
We were thus able to use both the unimolecular and the bimolecular conversion models to fit the 
kinetic data over the entire concentration range, particularly the oligomer concentrations (Fig. 3B 
and SI Appendix, Fig. S12B), to extract rate constants and a nucleation reaction order. A summary of 
the results is given in Figure 3, and the obtained values are in agreement with our earlier studies (27, 
28). In both cases we obtain a nucleation reaction order 𝑛 close to one, suggesting that the initial 
nucleation step governed by 𝑘𝑛 is a non-elementary step, for example a change in conformation, 
which can be resolved in principle into a series of steps by more detailed modelling. 
 
A unimolecular conversion model explains the observed intermediate FRET histograms at low 
concentrations 
In order to distinguish between a unimolecular conversion mechanism and a bimolecular conversion 
mechanism, both models were used with their fitted rate constants to predict the numbers of low-
FRET and high-FRET oligomers with reaction time at concentrations below 10 µM, and these 
predictions are shown in Figure 4. A unimolecular conversion model predicts similar and stable 
relative abundance of low-FRET and high-FRET oligomers up to 54 hours during aggregation 
reactions under these conditions, whereas a bimolecular model predicts much larger variations with 
time between and within each population. The former finding is consistent with the observation of 
blurred single FRET peaks at these concentrations, shown in Figure 2B; the observed FRET behaviour 
is intermediate between the low-FRET and high-FRET extremes, whereas a bimolecular model would 
10 
 
predict significant dominance of the low-FRET population’s contribution to the overall FRET 
behaviour. A unimolecular conversion model is thus preferred and retained for further study below. 
The unimolecular conversion model gives a rate constant for each conversion step of 9.5 x 10-2 h-1 
giving a half-life of each of the conversion steps of the aggregation reaction, outlined in Figure 3A, of 
about 7 hours. The overall characteristic reaction time, as measured by an inflection in the 
production of fibril mass with time, is given by this model as 34 hours for 140 μM, and 183 hours for 
0.5 μM. The value of k+ obtained here, 25 M-1 s-1, for the addition of monomer to a short fibril is 
slower than that obtained for the addition of monomer to large fibrils under similar but not identical 
conditions (22). This suggests that the short fibrils formed early in the aggregation process still differ 
in structure from mature fibrils.  
 
 
Seeding predictions from the unimolecular conversion model 
 
In templated seeding, the addition of pre-formed aggregates to the protein solution causes the 
acceleration of the aggregation reaction (36). Seeding by ɑS fibrils has been efficient in vitro (22, 37). 
However, determining whether oligomers of ɑS can also take part in the process of seeding has been 
difficult experimentally, since they are present in low concentrations during the aggregation process, 
their different types are hard to isolate and stabilize, and the precise quantification of these seeds 
prior to their addition remains challenging. Experimental evidence exists for both the promotion (38) 
and the inhibition (39) of aggregation reaction induced by various ɑS oligomers.  
 
Having established the extended kinetic model that is consistent with all the experimental data we 
used this model to explore the impact of seeding with either high-FRET oligomers or small fibrils. 
Low-FRET oligomers were not considered in this analysis owing to their demonstrated lower stability 
(27, 28). We determined the concentrations of either high-FRET oligomers or small fibrils that are 
required to double the initial aggregation rate of ɑS over a 1010-fold range of the different initial 
concentrations of ɑS (see SI Appendix, Fig. S13). According to the predictions, lower concentrations 
of fibrils than of oligomers are required in order to double the aggregation rate of ɑS, meaning that 
fibrils will be more prone to seed this reaction if present at equal concentrations. In addition, we 
assessed how sensitive the system is to seeding over the explored ɑS monomer concentration range, 
by looking at the ratio of the monomer concentration to seed concentration, termed “effectiveness” 
(SI Appendix, Fig. S13). The results reveal that the impact of seeding will vary not only depending on 
the nature of the seeds, but also on the initial ɑS monomer concentration (34); below 10 nM of 
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monomeric ɑS seeding by either types of aggregates will be relatively ineffective, whereas will 
become effective between 10 nM-1 µM, and particularly prominent at the concentrations above 1 
µM.   
To assess the role of seeds in ɑS aggregation at more physiologically-related conditions, we 
estimated the numbers of oligomers or fibrils that would need to be introduced to a volume 
approximately corresponding to a single cell (10 µm)3 in order to double the aggregation rate in the 
presence of a set of chosen initial concentrations of ɑS, which include the range of reported in vivo 
concentrations of ɑS (40, 41). According to the kinetic model, above the CɑS the seeding will result in 
the formation of fibrils, while below the CɑS it will lead to faster production of oligomers. Table 1 
summarises these predictions, and the first column lists the initial concentrations of ɑS, followed by 
columns containing the numbers of either high-FRET oligomers or fibrils that are required to be 
added to these initial concentrations to double the aggregation rate. In addition, Table 1 includes 
the concentrations of ɑS monomer that would be needed to prepare the required oligomer seed 
numbers during the aggregation process. Following these predictions, if the monomer concentration 
is 2 µM, 10,000 fibrils are needed, or 16,000 high-FRET oligomers, and an approximately five times 
higher (9.4 µM) concentration of αS monomer would be required for the production of this number 
of oligomers. We have investigated how the resulting seed numbers vary upon either lowering or 
increasing the initial concentration of ɑS, as illustrated in Table 1, and the required seed numbers 
remained in the order of thousands of species. For example, at 2 nM concentration, which is the 
lowest ɑS concentration considered in this analysis, 2,700 high-FRET oligomers or 2,400 fibrils are 
needed to double the aggregation rate. The seed numbers at 3 µM and 4 µM of initial ɑS, mimicking 
the conditions of the protein overproduction (42, 43), are also included (Table 1).  
In order to investigate the effects of the elevated concentration of the initial monomeric ɑS on the 
aggregate production, we used the kinetic model to estimate the number of oligomers that would 
be formed in a 48-hour period at the initial ɑS monomer concentration of 2 μM in the (10 µm)3 
volume, and determined how this number changes if the concentration is 3 μM instead (SI Appendix, 
Fig. S14). This analysis shows that the simulated cell-like volume would contain about 104 oligomers 
in a period of 48 hours, if there was no inhibition of the aggregation reaction. This number is again 
large, of the same order of magnitude as the numbers of species required for seeding, although, for 
example, the number of proteasomes available for the degradation in a biological cell was estimated 
to be about 1 million (44). However, if the oligomers were degraded significantly slower than 
monomers then oligomer formation could reduce the overall rate of proteasomal degradation in a 
cell. Interestingly, the consequence of the increased initial monomer concentration of ɑS from 2 μM 
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to 3 μM in this simulation is that higher concentrations of both oligomers and fibrils are produced at 
all times up to 48 hours (SI Appendix, Fig. S14). Considering the ability of oligomers to cause cellular 
damage, demonstrated in this and other studies (45), this observation is consistent with the 
established correlation between an increase in the concentration of ɑS and pathology. 
 
Discussion  
Here, we have exploited single-molecule FRET microscopy to study the initial steps of ɑS 
aggregation, and explored systematically the formation of oligomers over a range of the starting 
protein concentrations from 0.5 to 140 M. We then developed an extended kinetic model to 
analyse the experimental data over the full range of the examined ɑS concentrations, which allowed 
an estimation to be made of the rate constants of the main microscopic steps of the reaction shown 
in Figure 3A, and making predictions of number of ɑS seeds required to increase the aggregation 
rate, providing an insight into the conditions when the process of templated seeding might be 
favourable.  
Following our predictions, templated seeding by fibrils will enable the aggregation reaction to 
proceed to growth of more fibrils by monomer addition, without the steps dependent on the 
formation and conversion of oligomers. Seeding is expected to be particularly effective at minimum 
concentrations of ɑS above 1 µM (SI Appendix, Fig. S13), supporting the importance of ɑS 
concentration elevation in the disease. To quantify the number of seeds required to impact on the 
aggregation rate of ɑS in a volume approximately corresponding to a single cell (10 µm)3 , we 
estimated how many oligomers or fibrils would need to be introduced to this volume in order to 
double the aggregation rate of ɑS (Table 1). Clearly, these calculations do not aim to address various 
complex factors of the cellular environment, among which are, for example, the presence of cellular 
organelles and lipid surfaces, or altered salt content and pH that could increase the number of 
aggregates (22, 25), or molecular chaperones (46) and protein degradation systems (47), which 
prevent aggregate formation and remove aggregates once formed. Nevertheless, the predicted seed 
numbers based on our analysis provide a quantitative insight into the requirements to observe 
effective templated seeding of ɑS in vitro, which is significant because quantification of this process 
is currently lacking due to experimental difficulties in its elucidation. The predicted numbers of 
aggregates are large, in the order of 104 species per cell-like volume, values which corresponds to 
micromolar concentrations of the aggregates, requiring multiple species to enter this volume at the 
same time. These requirements for the templated seeding of ɑS are relatively high in comparison to, 
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for example, recently reported results for tau K18 using a similar approach (26). It is interesting to 
note that our kinetic analysis can be used to predict some of the conditions when a small number of 
oligomers or fibrils may be effective at seeding the aggregation reaction, and hence templated 
seeding might readily occur. Two factors appear to be important for this process to be favourable. 
The first determining factor is the nucleation rate, and if the nucleation rate is slow then a small 
number of oligomers or fibrils are most effective. For example, if the nucleation rate of ɑS is reduced 
in our model by a factor of 103, which is close to the published nucleation rate for the tetrapeptide 
repeat of tau (26), but all the other rates remain the same, then the number of high-FRET oligomers 
required to double the initial aggregation rate at 2 μM in the (10 μm)3 volume would be reduced 
approximately 39-fold, from 16,000 to 410. In order for a single high-FRET oligomer to be required 
for templated seeding, the nucleation rate constant of ɑS must be reduced by a markedly larger 
factor of 108. The other determining factor is the initial protein concentration, and whether it is 
above or below the critical aggregation concentration, which at our conditions was found to be 0.7 
μM for ɑS. At 2 μM, above the critical aggregation concentration, 16,000 oligomers are needed while 
below it, at 0.2 μM, only 5,900 oligomers will be sufficient. These oligomers, if added to a 
hypothetical cell, will lead to the faster formation of more oligomers, but not fibrils. Therefore, 
templated seeding will be more effective at low concentrations of free monomer. 
It is interesting to discuss our seeding predictions in the context of prion-like propagation of ɑS, 
since the processes of templated seeding and prion-like spreading have been frequently linked in 
literature (16). However despite occurring at the same time, the processes can be distinguished at 
the molecular level, as is schematically illustrated in Figure 5, and the templated seeding mechanism 
only constitutes a part of the spreading process. Templated seeding results in an accelerated 
production of protein aggregates. In isolation, this would lead to the formation of aggregates and 
followed by their passive diffusion (Fig. 5B). In order to achieve sustainable aggregate-driven 
spreading and prevent dilution of aggregates as they propagate from cell to cell, a process of 
aggregate amplification is essential in addition to templated seeding (Fig. 5C). In combination, these 
two processes would create a positive feedback loop, involving aggregate production and 
multiplication, resulting in the aggregate-driven (prion-like) spreading of ɑS, schematically shown in 
Figure 6A. Therefore effective prion-like spreading of ɑS in vivo requires a combination of conditions 
favouring both the templated seeding and the aggregate amplification processes. However, although 
ɑS aggregate amplification was demonstrated in vitro at low pH (22), we detected no amplification 
at neutral pH in these experiments and thus additional cellular based processes are needed, not 
included in the kinetic model, to achieve the aggregate amplification required for sustained 
spreading.  
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We have found that the oligomers of ɑS produced during the aggregation process are neurotoxic, 
which is consistent with our previous work (27). Using ROS measurements, we estimated that the 
numbers of oligomers required to promote the production of ROS in neuronal cells under our 
experimental conditions are in the order of tens of oligomers, which is similar to earlier results 
reported for amyloid-beta peptide, where cellular damage was found to occur when a single 
oligomer entered a recipient cell (48). The numbers of aggregates required for ROS production are 
therefore two orders of magnitude lower than what is required for the templated seeding, and such 
difference suggests that the templated seeding by the oligomers occurs less readily than the cellular 
damage caused by the aggregates themselves. This idea is consistent with the long-established link 
between the oxidative stress and neurodegeneration (49), and the fact that the oxidative reactions 
can promote the aggregation of ɑS (50), and is corroborated by experimentally observed correlation 
between ɑS seeding and cellular toxicity (15). Based on our findings, we hypothesize that for small 
aggregates in vivo, if templated seeding occurs it is under conditions of raised levels of ROS, which in 
turn may promote ɑS aggregation, resulting in the aggregate spreading in a cell-driven way that does 
not strongly depend on the seeding effectiveness, as illustrated in Figure 6B. Since our results 
suggest that cellular stress is required for sustained spreading, and larger ɑS fibrils were previously 
found less effective at exerting it (27), this implies that a larger number of fibrils than of oligomers 
will be required for the spreading to occur. Taken together, our quantitative analysis suggests that 
the mechanism of templated seeding by oligomers or fibrils is unlikely to solely drive the spreading 
of ɑS aggregates in PD, since this will always occur under conditions of cellular stress. Ultimately, this 
suggests that reducing cellular stress may be a possible therapeutic strategy to prevent the spread of 
disease through the brain.   
 
Summary 
In summary, we have characterised the early stages of ɑS aggregation using in vitro single-molecule 
experiments and kinetic analysis. Our proposed model treats the initially formed low-FRET 
oligomers, the more compact high-FRET oligomers and the fibrils of ɑS as distinct species, requiring 
successive conversion steps. The combination of single-molecule measurements and kinetic analysis 
used in this study has provided a quantification of ɑS aggregates in seeding the aggregation process, 
which is important in the context of PD, and the approach is applicable to other peptides and 
proteins that are likely to be involved in neurodegenerative diseases.  
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Methods 
αs Sample Preparation for sm-FRET 
Monomeric full-length A90C and wild-type ɑS were expressed and purified according to previously 
described protocol (51). A90C was labelled with maleimide-linked Alexa Fluor 488 (AF488) or Alexa 
Fluor 594 (AF594) (Life Technologies) and separated from the free dyes according to the previously 
reported protocol (27, 28, 52). Aliquots were flash-frozen, stored at –80°C and thawed once before 
use. For sm-FRET aggregation experiments, a 1:1 molar ratio of AF488 and AF594-labelled 
monomeric ɑS were combined in Tris buffer (25 mM Tris, 0.1 M NaCl, pH 7.4) with 0.01% NaN3, up to 
a starting protein concentration of either 0.5, 5, 10, 35, 70 or 140 µM and a sample volume of 300 
µL. It is established that ɑS aggregation in vitro can be promoted by constant agitation (53), 
therefore the solutions were incubated in the dark at 37°C with constant agitation at 200 rpm (New 
Brunswick Scientific Innova 43), and aliquots were withdrawn at regular intervals for sm-FRET 
experiments. The purity of the starting material was confirmed by sm-FRET measurements of the 
samples prior to the incubation. 
sm-FRET Data Acquisition 
Aliquots from the dual-labelled aggregating samples were diluted by a serial dilution 103-105-fold in 
Tris buffer at room temperature immediately before the measurement, a concentration suitable for 
single-molecule analysis, keeping the multiple occupancy events negligible. The analysed solution 
was introduced into an inlet of a straight-channelled microfluidic device (PDMS, 25 µm height, 100 
µm length) via a gel-loading tip, and passed through the channel at a constant rate of 2 cm/s by a 
syringe pump (PHD2000, Harvard Apparatus), according to the previously reported method (29). 
The setup used for single-molecule measurements (Fig. 1B) was analogous to previously described 
(54). For the FRET measurement, a collimated 488 nm laser beam (Spectra Physics NewPort Cyan) 
was directed through a back port of an inverted microscope (Nikon Eclipse Ti-U) at 2 mW power 
(measured at the back port of the microscope), where it was reflected by a dichroic mirror (Semrock 
DiO1 R405/488/594) and sent through an oil immersion objective (Plan Apo VC 60 x, NA 1.40, Nikon) 
to be focused 10 µm into the centre of the microfluidic channel. Fluorescence signal was collected by 
the same objective, imaged onto a 100 µm pinhole (Thorlabs) and separated into two channels by a 
dichroic mirror (Horiba 585DRLP). Donor fluorescence was filtered by a long-pass (Edge Basic 514) 
and a band-pass filter (535AF45 Omega Filters) before being focused onto an avalanche photodiode, 
APD (Perkin Elmer). Acceptor fluorescence was directed through a long-pass filter (610ALP Horiba) 
and a band-pass filter (BrightLine 629/53) before being focused onto a second APD. Synchronous 
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output from the APDs was collected by custom-implemented field-programmable gate array, FPGA 
(Celoxica RC10). Data were acquired for 400 s (80 frames, 100,000 bins per frame, 50 µs bin-width) 
per aliquot, and consisted of time-binned photon bursts in the donor and the acceptor channel (SI 
Appendix, Fig. S5). It was verified that the chosen experimental conditions and the detection time 
lead to the stable rate of coincident events (SI Appendix, Fig. S6), suggesting the absence of oligomer 
dissociation during the measurements. 
sm-FRET Data Analysis 
Data were analysed using custom-written Igor Pro (Wavemetrics) code, according to a previously 
reported method (28). Time-bins with intensities greater than 15 photons/bin in the donor (emission 
from AF488) and the acceptor (AF594) channel simultaneously (the AND criterion) (55) were 
assigned to be due to oligomeric events and selected for the analysis. The donor counts which did 
not fit the criterion but were above the applied threshold were saved separately and assigned as 
monomeric αs bursts. The threshold of 15 photons/bin for both channels was determined using the 
previously established optimised threshold selection method (56). The values of the photon bursts 
were corrected for the cross-talk and the autofluorescence from the donor to acceptor channels 
according to  DD ADI  , where ID  is the modified intensity in the donor channel, D is the original 
intensity in the donor channel, AD is the autofluorescence in the donor channel (1.6 photons/bin, the 
average signal from buffer only), and  DCAAI AA  , where IA  is the modified intensity in the 
acceptor channel, A is the original intensity in the acceptor channel, AA is the autofluorescence in the 
acceptor channel (1.3 photons/bin), C is the cross-talk from donor to acceptor channel (13%). The 
crosstalk was negligible from the acceptor to donor channel. 
For every simultaneous oligomeric burst, the FRET efficiency was calculated: 
)( DA
A
II
I
E


                                                                       (1) 
where ID is the donor intensity in the presence of an acceptor, IA is the acceptor intensity and   is the 
gamma factor specific to the instrument (0.99), which accounts for the relative detection efficiencies 
of the dyes and their quantum yield.   
The FRET efficiency values were binned into histograms with bin width of 0.05 (Fig.2). 
Subsequently, the data were split into two size groups: small (2-5-mers) and large (6-150-mers). 
Large species, either occupying consecutive time-bins or greater than 150-mers, were excluded from 
the analysis as detailed in Horrocks et. al. (29). At small sizes, one peak was observed in the FRET 
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efficiency histograms in all measured samples (SI Appendix, Fig. S4). At large sizes, either one (at 0.5-
10 µM), or two (at 35-140 µM) FRET efficiency peaks could be distinguished. The two distinguishable 
peaks were assigned to be due to low-FRET oligomers and high-FRET oligomers. The FRET efficiency 
histograms were integrated to give oligomer kinetic traces, as detailed in SI Appendix, section 1.1. 
For 0.5-10 µM samples, the overall change in oligomer populations was obtained. For 35-140 µM 
samples, the separate kinetic traces for low-FRET and high-FRET oligomers were resolved. 
Kinetic Analysis 
The following kinetic moment equations were used to model the aggregation of ɑS, neglecting the 
relatively slow reverse conversions and depolymerization reactions: 
Monomer independent unimolecular conversion model: 
(2) 
?̇?1(𝑡) =  𝑘𝑛𝑚(𝑡)
𝑛 −  𝑘1
𝑐𝑃1(𝑡), 
?̇?2(𝑡) =  𝑘1
𝑐𝑃1(𝑡) − 𝑘2
𝑐𝑃2(𝑡), 
?̇?3(𝑡) =  𝑘2
𝑐𝑃2(𝑡), 
?̇?1(𝑡) =  𝑛𝑘𝑛𝑚(𝑡)
𝑛 −  𝑘1
𝑐𝑀1(𝑡) +  2𝑘1
+𝑚(𝑡)𝑃1(𝑡), 
?̇?2(𝑡) =  𝑘1
𝑐𝑀1(𝑡) −  𝑘2
𝑐𝑀2(𝑡) +  2𝑘2
+𝑚(𝑡)𝑃2(𝑡), 
?̇?3(𝑡) =  𝑘2
𝑐𝑀2(𝑡) +  2𝑘+𝑚(𝑡)𝑃3(𝑡), 
𝑚(𝑡) =  𝑚𝑡𝑜𝑡 − 𝑀1(𝑡) − 𝑀2(𝑡) −  𝑀3(𝑡) 
 
Monomer dependent bimolecular conversion model: 
?̇?1(𝑡) =  𝑘𝑛𝑚(𝑡)
𝑛 −  𝑚(𝑡) 𝑘1
𝑐𝑃1(𝑡), 
?̇?2(𝑡) =  𝑚(𝑡) 𝑘1
𝑐𝑃1(𝑡) −  𝑚(𝑡) 𝑘2
𝑐𝑃2(𝑡), 
?̇?3(𝑡) =  𝑚(𝑡) 𝑘2
𝑐𝑃2(𝑡), 
?̇?1(𝑡) =  𝑛𝑘𝑛𝑚(𝑡)
𝑛 −  𝑚(𝑡) 𝑘1
𝑐𝑀1(𝑡) +  2𝑘1
+𝑚(𝑡)𝑃1(𝑡), 
?̇?2(𝑡) =  𝑚(𝑡) 𝑘1
𝑐𝑀1(𝑡) −  𝑚(𝑡) 𝑘2
𝑐𝑀2(𝑡) +  2𝑘2
+𝑚(𝑡)𝑃2(𝑡), 
?̇?3(𝑡) =  𝑚(𝑡) 𝑘2
𝑐𝑀2(𝑡) +  2𝑘+𝑚(𝑡)𝑃3(𝑡), 
𝑚(𝑡) =  𝑚𝑡𝑜𝑡 − 𝑀1(𝑡) − 𝑀2(𝑡) −  𝑀3(𝑡) 
where: 
P1 = number concentration of low-FRET oligomers, 
P2 = number concentration of high-FRET oligomers, 
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P3 = number concentration of fibrils, 
M1 = mass concentration of low-FRET oligomers (concentration of monomer residues 
involved), 
M2 = mass concentration of high-FRET oligomers (concentration of monomer residues 
involved), 
M3 = mass concentration of fibrils (concentration of monomer residues involved), 
m(t) = concentration of free monomer units, 
mtot = total concentration of monomer in the system, 
k1
+ = rate constant governing growth of low-FRET oligomers, 
k2
+ = rate constant governing growth of high-FRET oligomers. 
All other symbols are defined in Figure 3 and SI Appendix, Figure S12. 
These moment equations are derived by taking sums of the system’s kinetic master equations over 
the length distribution of each species, as previously described (31-34). Both models are first 
linearized for early times by taking 𝑚(𝑡) =  𝑚𝑡𝑜𝑡 (discarding the last equation in each case) and then 
solved analytically using the Mathematica 10.0 software package, to obtain closed-form expressions 
for each population. Initial conditions were chosen according to the seeding scenario explored (for 
data fitting, unseeded conditions are represented by 𝑃1(0) =  𝑃2(0) =  𝑃3(0) =  𝑀1(0) =  𝑀2(0) =
 𝑀3(0) = 0 and 𝑚(0) =  𝑚𝑡𝑜𝑡. The resulting expressions were then globally fitted to experimental 
data up to 33 h for a range of values for 𝑚𝑡𝑜𝑡 via a weighted least-squares Levenberg-Marquardt 
algorithm, leaving all rate constants and the nucleation reaction order free (see Fig. 3 and SI 
Appendix, Fig. S12). The negligible mass of oligomers observed throughout the aggregation reaction 
suggests that the consumption of monomer mass by growth of oligomers can be neglected; terms 
involving 𝑘1
+ and 𝑘2
+ were thus neglected in both models, with no adverse effect observed on the 
quality of the resulting fits. Furthermore, 𝑘1
𝑐 and 𝑘2
𝑐 were equated into a single parameter 𝑘𝑐 in each 
model, as described in the main text in the Kinetic Analysis section. 
The overall characteristic reaction time 𝑡𝑎 in the unimolecular model, as measured by the time at 
which an inflection is observed in the fibril mass concentration 𝑀3(𝑡) without linearization of the 
equations, is given to a good approximation by 𝑡𝑎 =  (2 𝑘+𝑘𝑛𝑚𝑡𝑜𝑡
𝑛 )−1/2 +  2 𝑘𝑐
−1 as described 
previously (34). For seeding simulations, a doubling in the initial reaction rate was quantified by 
considering a halving in the tenth time of the reaction upon seeding; that is, the time taken for the 
fibril mass concentration 𝑀3(𝑡) to reach 𝑚𝑡𝑜𝑡 / 10, which lies within the range of validity of the 
linearized early time solution described above. 
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Figure Legends:  
Fig. 1: Schematic representation of sm-FRET experiment to probe the aggregation of alpha-synuclein 
(ɑS). (A) 1:1 stoichiometric ratio of ɑS monomer labelled with Alexa Fluor 488 and Alexa Fluor 594, 
shown as blue and orange spheres, was combined at a given initial concentration and allowed to 
aggregate. During the process, the monomeric protein assembles into oligomers, the main focus of 
the present experiments, and then amyloid fibrils. Aliquots were withdrawn, diluted and analysed 
using a single-molecule microscope. (B) Schematic of the setup used for the single-molecule FRET 
experiments.  
 
Fig. 2: Results of the sm-FRET experiment. (A) Kinetic profiles of oligomer formation and monomer 
depletion, plotted against the incubation time (SEM, N=6, N is a separate sample). To note, the 
increase in the oligomer concentrations for 0.5 µM solutions is present and the resulting species are 
in the low-nanomolar range, which is not readily visible on the scale in A. Magnification is shown in 
SI Appendix, Figure S7A. (B) Representative FRET efficiency histograms, resulting from sm-FRET 
aggregation experiments with initial protein concentrations of 5, 10, 70 and 140 µM, detected over 
400 s. The data were split into two apparent size groups: small (2-5 monomer units) and large (6-150 
monomer units) oligomers. For the large oligomers, illustrative fits to Gaussian functions are shown 
in blue (SI Appendix, eq. S1), and the resulting mean FRET efficiency values, E, were: for 5 µM, 9 h 
E=0.34, 27 and 51 h global E=0.49; for 10 µM, 9 h E=0.33, 27 and 51 h global E=0.52; for 70 µM, 
global E(low-FRET)=0.37 and global E(high-FRET)=0.71; for 140 µM, global E(low-FRET)=0.44 and 
global E(high-FRET)=0.67. Further details of the fitting functions and the resulting average 
parameters (N=6) are given in SI Appendix, section 1.1. 
 
Fig. 3. Modelling the kinetics of ɑS aggregation. (A) The model considers coarse-grained conversion 
reaction between oligomeric populations as a whole, with no size dependence, and allows fibrils to 
grow once formed. Here, unimolecular conversions with no monomer dependence are assumed 
between populations (an alternative model with bimolecular conversions is presented in SI 
Appendix, Figure S12A). (B) The resulting nucleation-conversion-polymerization model is used to 
describe the observed populations, whereby monomer units form low-FRET efficiency oligomers 
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with rate constant kn and an average reaction order of n. These oligomers can then convert to 
ordered high-FRET efficiency oligomers via a first-order reaction with rate constant k1
c, with a 
subsequent final first-order conversion to fibrils with rate constant k2
c. Fibrils can then recruit single 
monomer units to grow in a succession of elongation steps, with a length-independent rate constant 
k+. At early reaction times, reverse reactions can be neglected, and conversion constants were fixed 
as equal such that k1
c
= k2
c≡ kc .The resulting simplified model, with four free parameters, was fitted 
globally to early-time (up to 33 hours) kinetic data showing changes with time in monomeric and 
oligomeric populations for a range of initial monomer concentrations. The resulting nucleation 
reaction order was found to be n= 0.90 ± 0.1 with rate constants kn = (4.0 ± 2.0) x 10
-4 
µM
1-n
h
-1
, kc = 
(9.5 ± 5.0) x 10
-2 
h
-1
, and k+ = (9.0 ± 7.0) x 10
-2 
µM 
-1
h
-1
. 
 
Fig. 4. Predictions of ɑS aggregation kinetics at low concentrations by nucleation-conversion-
polmerization models. After fitting to the available kinetic data, both unimolecular (Fig. 3) and 
bimolecular (SI Appendix, Fig. S12) conversion models were used to predict how the concentrations 
of low-FRET efficiency oligomers and high-FRET efficiency oligomers vary over time at low initial 
monomer concentrations; the fitting was carried out by considering only the total concentration of 
oligomers at these low monomer concentrations. As the fitting was carried out over a reaction time 
of 33 hours and overlaid over 54 hours, a similar time range was used for the predictions. From the 
third column, it is clear that a unimolecular conversion model alone predicts similar concentrations 
of both types of oligomers, and furthermore predicts a ratio of concentrations that is very stable 
with changing initial monomer concentration. These predictions are consistent with the single-peak 
FRET histograms at low concentrations shown in Figure 2B. 
 
Fig. 5. Schematic representation of the processes required for ɑS spreading. (A) Seeding results in 
the formation of aggregates from monomeric protein, and amplification involves the multiplication 
of existing aggregates. (B) Seeding process alone would not lead to efficient spreading due to the 
possibility that the formed aggregates would be diluted out. (C) The combination of seeding and 
amplification can lead to continuous aggregate spreading. 
 
Fig. 6. Schematic outline of two simplified models of ɑS aggregate spreading in cellular environment. 
(A) Aggregate-driven, or prion-like, propagation of aggregated species. The primary role of the 
aggregate upon entering a cell is to induce the aggregation of monomeric protein by the mechanism 
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of templated seeding. (B) Cell-driven model. The initial role of the aggregate is to induce cellular 
stress, which disrupts the homeostasis and creates conditions where protein aggregation becomes 
favourable. 
